Table 5.
Distribution of antimicrobial susceptibility test results of 131 methicillin-sensitive Staphylococcus aureus isolates from pediatric patients stratified by origin of acquisition
| Antibiotics | CA (n = 94) No. (%) |
HA (n = 37) No. (%) |
P | HA | ||
|---|---|---|---|---|---|---|
| CO (n = 17) No. (%) |
HO (n = 20) No. (%) |
P | ||||
| Clindamycin (%) | 75 (80) | 29 (78) | 0.858 | 12 (71) | 17 (85) | 0.289 |
| Erythromycin (%) | 66 (70) | 25 (68) | 0.767 | 11 (65) | 14 (70) | 0.732 |
| Fusidic acid (%) | 93 (99) | 35 (95) | 0.135 | 17 (100) | 18 (90) | 0.180 |
| Linezolid (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
| Penicillin (%) | 2 (2) | 8/36a (22) | 0 | 4 (24) | 4/19a (21) | 0.858 |
| Sufamethoxazole-Trimethoprim (%) | 94 (100) | 34/36a (94) | 0.021 | 16 (94) | 18/19a (95) | 0.935 |
| Teicoplanin (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
| Vancomycin (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
| iprofloxacin (%) | 93 (99) | 37 (100) | 0.529 | 17 (100) | 20 (100) | – |
| Doxycycline (%) | 92 (98) | 35 (95) | 0.326 | 15 (88) | 20 (100) | 0.115 |
CA community-associated, HA healthcare-associated, CO community onset, HO hospital onset
aLinezolid, Penicillin, Sufamethoxazole-Trimethoprim, Teicoplanin, Vancomycin each lost 1 datum in the HA column